The a2 Milk Company is publicly listed company on both the Australian and New Zealand stock exchanges. Whilst a large number of our shareholders are in Australia, followed by a smaller number in New Zealand, there are also shareholders from other countries.
Yes, we welcome your support and investment in The a2 Milk Company Limited. Shares are available for purchase on both the New Zealand Securities Exchange (NZX) and Australian Securities Exchange (ASX).
If you currently own shares and want to change your investor details, please contact:
|Postal address:||P O Box 91976
|Phone:||+64 9 375 5998|
|Fax:||+64 9 375 5990|
680 George Street
Sydney, NSW 2000
|Phone:||+61 1300 554 474|
|Fax:||+61 2 9287 0303|
The a2 Milk Company has trading activities in Australia, New Zealand, UK, China and the US.
You can read more about our businesses here.
The Investor Centre on The a2 Milk Company’s website contains the most recent financial information, including interim and annual reports, and investor presentations.
Please send us an email outlining the details and including your contact information, and we will respond as soon as possible.
The a2 Milk Company encourages the academic community to increase the research into the differences between the A2 protein and A1 protein within dairy and infant formula products and their potential impact on digestive outcomes for people who have difficulty drinking ordinary cows' milk.
The company will continue to pioneer and invest in understanding milk proteins and their potential unique health benefits. The a2 Milk Company has recently commissioned new human studies into the digestive benefits of drinking milk containing only the A2 protein and no A1 protein.